Vivani Medical (NASDAQ:VANI – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.
Vivani Medical Trading Down 0.9 %
NASDAQ VANI opened at $1.09 on Friday. The stock’s fifty day moving average price is $1.14 and its 200-day moving average price is $1.21. The stock has a market cap of $64.57 million, a P/E ratio of -2.42 and a beta of 3.20. Vivani Medical has a 12 month low of $1.03 and a 12 month high of $2.22.
Analysts Set New Price Targets
Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Vivani Medical in a research report on Thursday, March 13th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Five stocks we like better than Vivani Medical
- What Do S&P 500 Stocks Tell Investors About the Market?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What is a Bond Market Holiday? How to Invest and Trade
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Why Invest in 5G? How to Invest in 5G Stocks
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
